Related Experiment Video
Updated: Aug 16, 2025
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.3K
Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study
Azhar Mahmood Farooqui1, Amit Arya2, Amit Singh2
1Department of Psychiatry, Integral Institute of Medical Science and Research, Lucknow, Uttar Pradesh, India.
Addiction & Health
|December 22, 2022
Summary
Psychiatric comorbidities are common in individuals injecting opioids in India, impacting their psychosocial functioning. Early identification and intervention are crucial for better outcomes in this vulnerable population.
Area of Science:
- Addiction Medicine
- Psychiatry
- Public Health
Background:
- Injecting drug use (IDU) is a significant public health issue in India.
- IDU often co-occurs with psychiatric disorders, negatively impacting psychosocial functioning.
- This study focuses on opioid-dependent individuals who inject drugs.
Purpose of the Study:
- To assess psychiatric comorbidities in individuals who inject opioids.
- To evaluate psychosocial problems and global functioning in this population.
- To understand the relationship between comorbidities and functioning.
Main Methods:
- Cross-sectional study of 100 opioid-dependent individuals receiving buprenorphine maintenance treatment.
- Psychiatric disorders assessed using SCID-I (Axis-I) and SCID-II (Axis-II) based on DSM-IV-TR criteria.
- Psychosocial problems (Axis-IV), global functioning (GAF), and substance use severity (ASI) were also evaluated.
Main Results:
- 76% of participants exhibited psychiatric comorbidities, including mood disorders (28.95%), anxiety disorders (13.16%), and personality disorders (27.63%).
- Participants with comorbidities reported significantly higher psychosocial and environmental problems.
- Comorbid conditions were associated with poorer global functioning (GAF scores).
Conclusions:
- Psychiatric comorbidities are highly prevalent among individuals who inject opioids.
- These comorbidities are linked to substantial psychosocial and environmental challenges.
- Integrated treatment approaches, including early identification and community-based rehabilitation, are recommended for improved outcomes.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.3K
07:30Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
6.8K
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
608
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
608
01:24Substance Use Disorders Affecting Sleep
207
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
207
01:30Stress and Mental Health
195
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
195
01:25Analgesia and Pain Management
717
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
717
01:17Drug Dependence
1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
375
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
375